BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madsen A, Cox RJ. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines (Basel) 2020;8:E361. [PMID: 32640619 DOI: 10.3390/vaccines8030361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Vaccine 2021;39:6573-84. [PMID: 34602302 DOI: 10.1016/j.vaccine.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Becker T, Elbahesh H, Reperant LA, Rimmelzwaan GF, Osterhaus ADME. Influenza Vaccines: Successes and Continuing Challenges. J Infect Dis 2021;224:S405-19. [PMID: 34590139 DOI: 10.1093/infdis/jiab269] [Reference Citation Analysis]
3 Devi AB, Sarala R. Substantial effect of phytochemical constituents against the pandemic disease influenza-a review. Futur J Pharm Sci 2021;7:120. [PMID: 34150912 DOI: 10.1186/s43094-021-00269-5] [Reference Citation Analysis]
4 Ecker JW, Kirchenbaum GA, Pierce SR, Skarlupka AL, Abreu RB, Cooper RE, Taylor-Mulneix D, Ross TM, Sautto GA. High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines. Vaccines (Basel) 2020;8:E462. [PMID: 32825605 DOI: 10.3390/vaccines8030462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kiseleva I. New Points of Departure for More Global Influenza Vaccine Use. Vaccines (Basel) 2020;8:E410. [PMID: 32718042 DOI: 10.3390/vaccines8030410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]